Joel F. Martin

Joel F. Martin is the current President & CEO at Dauntless Pharmaceuticals. Joel has over 25 years of experience in the biotech industry, including positions as CEO and Partner at various companies.

Joel started their career in 1994 as the President & CEO of Argonaut Technologies. Joel then became the CEO of Quantum Dot Corporation in 1998. In 2001, they became a Partner at Forward Ventures. In 2009, they became the CEO of Altair Therapeutics. In 2012, they became the President & CEO of Cebix, Inc. In 2015, they became the President & CEO of Dauntless Pharmaceuticals Inc.

Martin has a long history of success in the biotech industry. Joel has a proven track record of being able to take companies and help them grow and succeed. Joel is an expert in the field and has a passion for helping others achieve their goals.

Joel F. Martin has an MBA from the University of Michigan - Stephen M. Ross School of Business, a PhD in Physical Chemistry from UC San Diego, and a BSChem Honors in Chemistry from the University of Michigan.

Michelle Mazzoni - Regulatory Affairs & Quality Consultant, Olivier Laurent - Chief Scientific Officer report to Joel F. Martin.